Marshall Wace, LLP Thermo Fisher Scientific Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 700 shares of TMO stock, worth $429,905. This represents 0.0% of its overall portfolio holdings.

Number of Shares

700

Previous 2,481 71.79%

Holding current value

$429,905

Previous $1.44 Million 73.14%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$541.52 - $599.02 $964,447 - $1.07 Million	-1,781 Reduced 71.79%	700 $387,000
Q1 2024 May 15, 2024	SELL	$528.82 - $599.43 $222 Million - $252 Million	-420,095 Reduced 99.41%	2,481 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$431.41 - $532.94 $182 Million - $225 Million	422,576 New	422,576 $224 Million
Q1 2023 May 15, 2023	SELL	$535.0 - $604.82 $198 Million - $224 Million	-370,095 Reduced 92.39%	30,479 $17.6 Million
Q4 2022 Feb 14, 2023	SELL	$484.71 - $571.37 $30.2 Million - $35.6 Million	-62,242 Reduced 13.45%	400,574 $221 Million
Q3 2022 Nov 14, 2022	SELL	$507.19 - $604.49 $130 Million - $155 Million	-255,698 Reduced 35.59%	462,816 $235 Million
Q2 2022 Aug 15, 2022	BUY	$500.9 - $612.21 $199 Million - $244 Million	398,226 Added 124.33%	718,514 $390 Million
Q1 2022 May 16, 2022	SELL	$524.0 - $644.92 $379 Million - $467 Million	-723,556 Reduced 69.32%	320,288 $189 Million
Q4 2021 Feb 14, 2022	BUY	$569.0 - $667.24 $364 Million - $427 Million	640,091 Added 158.54%	1,043,844 $696 Million
Q3 2021 Nov 15, 2021	SELL	$509.53 - $609.78 $49.1 Million - $58.8 Million	-96,414 Reduced 19.28%	403,753 $231 Million
Q2 2021 Aug 13, 2021	BUY	$441.0 - $508.24 $26.5 Million - $30.5 Million	60,052 Added 13.64%	500,167 $252 Million
Q1 2021 May 17, 2021	SELL	$439.85 - $518.83 $188 Million - $222 Million	-427,279 Reduced 49.26%	440,115 $201 Million
Q4 2020 Feb 16, 2021	BUY	$435.06 - $527.66 $151 Million - $184 Million	347,974 Added 66.99%	867,394 $404 Million
Q3 2020 Nov 16, 2020	SELL	$359.77 - $441.52 $20.6 Million - $25.3 Million	-57,258 Reduced 9.93%	519,420 $229 Million
Q2 2020 Aug 13, 2020	SELL	$275.2 - $362.34 $7.44 Million - $9.79 Million	-27,029 Reduced 4.48%	576,678 $209 Million
Q1 2020 May 15, 2020	SELL	$255.3 - $340.05 $80 Million - $107 Million	-313,495 Reduced 34.18%	603,707 $171 Million
Q4 2019 Feb 14, 2020	SELL	$271.93 - $328.04 $63.6 Million - $76.8 Million	-234,030 Reduced 20.33%	917,202 $298 Million
Q3 2019 Nov 14, 2019	BUY	$268.46 - $305.43 $18.8 Million - $21.4 Million	70,151 Added 6.49%	1,151,232 $335 Million
Q2 2019 Aug 14, 2019	BUY	$257.51 - $295.55 $78.8 Million - $90.4 Million	305,978 Added 39.48%	1,081,081 $317 Million
Q1 2019 May 14, 2019	BUY	$212.17 - $273.72 $129 Million - $166 Million	607,245 Added 361.76%	775,103 $212 Million
Q4 2018 Feb 14, 2019	BUY	$208.47 - $251.98 $35 Million - $42.3 Million	167,858 New	167,858 $37.6 Million
Q4 2017 Feb 14, 2018	SELL	$182.03 - $200.37 $8.05 Million - $8.86 Million	-44,224 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$171.74 - $194.04 $7.6 Million - $8.58 Million	44,224	44,224 $8.36 Million

Others Institutions Holding TMO

# of Institutions

2,778

Shares Held

340M

Call Options Held

1.42M

Put Options Held

2.15M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $241B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Thermo Fisher Scientific Inc. Transaction History